CD137 (4–1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice
Hyung Jun Jeon(Seoul National University), Goo Taeg Oh(Ewha Womans University), Se‐Jin Jeong(Washington University in St. Louis), Jong‐Gil Park(Georgia Institute of Technology), Beom K. Choi(National Cancer Center), Byoung S. Kwon(Massachusetts General Hospital), In‐Hyuk Jung(Amgen (United States)), Dae-Yong Kim(National Cancer Center), Hyun‐Young Park(Korea National Institute of Health), Jae‐Hoon Choi(Georgia Institute of Technology), Mi‐Ran Lee(Georgia Institute of Technology), Mi-Ni Lee(Ewha Womans University), Bora Kim(Seoul National University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Jeong Euy Park(Samsung Medical Center), KyuBum Kwack(CHA University)
Cited by 119
Related Papers
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332
Air Pollution and Central Nervous System Disease: A Review of the Impact of Fine Particulate Matter on Neurological Disorders
|Frontiers in Public Health|2020|207
Targeting immune–fibroblast cell communication in heart failure
|Nature|2024|198
Four SNPs on Chromosome 9p21 in a South Korean Population Implicate a Genetic Locus That Confers High Cross-Race Risk for Development of Coronary Artery Disease
|Arteriosclerosis Thrombosis and Vascular Biology|2007|196